Adverse medical events in British service personnel following anthrax vaccination

By Enstone J.E.   Wale M.C.J.   Nguyen-Van-Tam J.S.   Pearson J.C.G.  

Vaccine, Vol. 21, Iss. 13, 2003-03 ,pp. : 1348-1354

Elsevier

Access to resources Recommend Favorite

Vaccination against Lyme Disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses

By Chang Y.-F.   Novosol V.   McDonough S.P.   Chang C.-F.   Jacobson R.H.   Divers T.   Quimby F.W.   Shin S.   Lein D.H.  

Vaccine, Vol. 18, Iss. 5, 1999-10 ,pp. : 540-548

Elsevier

Access to resources Recommend Favorite

Adverse event reporting rates following tetanus-diphtheria and tetanus toxoid vaccinations: data from the Vaccine Adverse Event Reporting System (VAERS), 1991-1997

By Lloyd J.C.   Haber P.   Mootrey G.T.   Braun M.M.   Rhodes P.H.   Chen R.T.   VAERS Working Group  

Vaccine, Vol. 21, Iss. 25, 2003-09 ,pp. : 3746-3750

Elsevier

Access to resources Recommend Favorite

Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination

By Niu M.T.   Erwin D.E.   Braun M.M.  

Vaccine, Vol. 19, Iss. 32, 2001-09 ,pp. : 4627-4634

Elsevier

Access to resources Recommend Favorite

Vaccination of natural reservoir hosts with recombinant lipidated OspA induces a transmission-blocking immunity against Lyme disease spirochaetes associated with high levels of LA-2 equivalent antibodies

By Kurtenbach K.   Dizij A.   Voet P.   Hauser P.   Simon M.M.  

Vaccine, Vol. 15, Iss. 15, 1997-10 ,pp. : 1670-1674

Elsevier

Access to resources Recommend Favorite